Literature DB >> 33576785

Reports of Anaphylaxis After Receipt of mRNA COVID-19 Vaccines in the US-December 14, 2020-January 18, 2021.

Tom T Shimabukuro1, Matthew Cole2, John R Su1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33576785      PMCID： PMC8890485          DOI： 10.1001/jama.2021.1967

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  8 in total

1.  Anaphylaxis: case definition and guidelines for data collection, analysis, and presentation of immunization safety data.

Authors:  Jens U Rüggeberg; Michael S Gold; José-Maria Bayas; Michael D Blum; Jan Bonhoeffer; Sheila Friedlander; Glacus de Souza Brito; Ulrich Heininger; Babatunde Imoukhuede; Ali Khamesipour; Michel Erlewyn-Lajeunesse; Susana Martin; Mika Mäkelä; Patricia Nell; Vitali Pool; Nick Simpson
Journal:  Vaccine       Date:  2007-03-12       Impact factor: 3.641

Review 2.  Safety monitoring in the Vaccine Adverse Event Reporting System (VAERS).

Authors:  Tom T Shimabukuro; Michael Nguyen; David Martin; Frank DeStefano
Journal:  Vaccine       Date:  2015-07-22       Impact factor: 3.641

Review 3.  Vaccine-associated hypersensitivity.

Authors:  Michael M McNeil; Frank DeStefano
Journal:  J Allergy Clin Immunol       Date:  2018-02       Impact factor: 10.793

4.  Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Moderna COVID-19 Vaccine - United States, December 21, 2020-January 10, 2021.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2021-01-29       Impact factor: 17.586

5.  The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine - United States, December 2020.

Authors:  Sara E Oliver; Julia W Gargano; Mona Marin; Megan Wallace; Kathryn G Curran; Mary Chamberland; Nancy McClung; Doug Campos-Outcalt; Rebecca L Morgan; Sarah Mbaeyi; José R Romero; H Keipp Talbot; Grace M Lee; Beth P Bell; Kathleen Dooling
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2020-12-18       Impact factor: 17.586

6.  The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Moderna COVID-19 Vaccine - United States, December 2020.

Authors:  Sara E Oliver; Julia W Gargano; Mona Marin; Megan Wallace; Kathryn G Curran; Mary Chamberland; Nancy McClung; Doug Campos-Outcalt; Rebecca L Morgan; Sarah Mbaeyi; José R Romero; H Keipp Talbot; Grace M Lee; Beth P Bell; Kathleen Dooling
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2021-01-01       Impact factor: 35.301

7.  Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine.

Authors:  Tom Shimabukuro; Narayan Nair
Journal:  JAMA       Date:  2021-02-23       Impact factor: 56.272

8.  Excess Deaths Associated with COVID-19, by Age and Race and Ethnicity - United States, January 26-October 3, 2020.

Authors:  Lauren M Rossen; Amy M Branum; Farida B Ahmad; Paul Sutton; Robert N Anderson
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2020-10-23       Impact factor: 17.586
  8 in total
  134 in total

Review 1.  To PEGylate or not to PEGylate: Immunological properties of nanomedicine's most popular component, polyethylene glycol and its alternatives.

Authors:  Da Shi; Damian Beasock; Adam Fessler; Janos Szebeni; Julia Y Ljubimova; Kirill A Afonin; Marina A Dobrovolskaia
Journal:  Adv Drug Deliv Rev       Date:  2021-12-10       Impact factor: 15.470

2.  Best Practices for COVID-19 Mass Vaccination Clinics.

Authors:  Shima Shakory; Azza Eissa; Tara Kiran; Andrew D Pinto
Journal:  Ann Fam Med       Date:  2022 Mar-Apr       Impact factor: 5.166

3.  Skin testing with Pfizer SARS-CoV-2 vaccine and PEG 2000.

Authors:  João Vieira; João Marcelino; Fátima Ferreira; Sofia Farinha; Rita Silva; Miguel Proença; Elza Tomaz
Journal:  Asia Pac Allergy       Date:  2021-04-26

4.  Cough, coronavirus disease 2019, the vaccines, and allergy.

Authors:  Yoon-Seok Chang
Journal:  Asia Pac Allergy       Date:  2021-04-30

5.  Safety of BNT162b2 mRNA COVID-19 vaccine in patients with mast cell disorders.

Authors:  Yossi Rosman; Noa Lavi; Keren Meir-Shafrir; Idit Lachover-Roth; Anat Cohen-Engler; Yoseph A Mekori; Ronit Confino-Cohen
Journal:  J Allergy Clin Immunol Pract       Date:  2021-07-02

6.  COVID-19 vaccine-related presumed allergic reactions and second dose administration by using a two-step graded protocol.

Authors:  Gayatri B Patel; Krishan D Chhiba; Michael M Chen; Amina Guo; Melissa M Watts; Jane Cullen; Bruce S Bochner; Leslie C Grammer; Paul A Greenberger; Carol A Saltoun; Whitney W Stevens; Fei Li Kuang; Anju T Peters
Journal:  Allergy Asthma Proc       Date:  2021-11-01       Impact factor: 2.587

7.  Surveillance for Adverse Events After COVID-19 mRNA Vaccination.

Authors:  Nicola P Klein; Ned Lewis; Kristin Goddard; Bruce Fireman; Ousseny Zerbo; Kayla E Hanson; James G Donahue; Elyse O Kharbanda; Allison Naleway; Jennifer Clark Nelson; Stan Xu; W Katherine Yih; Jason M Glanz; Joshua T B Williams; Simon J Hambidge; Bruno J Lewin; Tom T Shimabukuro; Frank DeStefano; Eric S Weintraub
Journal:  JAMA       Date:  2021-10-12       Impact factor: 56.272

Review 8.  COVID-19: vaccination problems.

Authors:  Harald Brüssow
Journal:  Environ Microbiol       Date:  2021-05-14       Impact factor: 5.476

9.  COVID-19 mRNA Vaccine and Myocarditis.

Authors:  Balraj Singh; Parminder Kaur; Leon Cedeno; Taulant Brahimi; Prem Patel; Hartaj Virk; Fayez Shamoon; Manesh Bikkina
Journal:  Eur J Case Rep Intern Med       Date:  2021-06-14

10.  First Dose mRNA COVID-19 Vaccine Allergic Reactions: Limited Role for Excipient Skin Testing.

Authors:  Anna R Wolfson; Lacey B Robinson; Lily Li; Aubree E McMahon; Amelia S Cogan; Xiaoqing Fu; Paige Wickner; Upeka Samarakoon; Rebecca R Saff; Kimberly G Blumenthal; Aleena Banerji
Journal:  J Allergy Clin Immunol Pract       Date:  2021-06-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.